4,4'-DI(FURAN-2-YL)-6,6'-DIMETHYL-2,2'-BIPYRIDINE, 95.0%, 1g

6-CHLOROISOQUINOLIN-3-AMINE, 95.0%, 1g

3-BENZOYLBENZOIC ACID, 95.0%, 5g

5,5-dimethylpiperazin-2-one, 95.0%, 250mg

1-(11,12-Didehydrodibenz[b,f]azocin-5(6H)-yl)ethanone, 98%, 250mg

Acide maléique, min 99 %, 100 g, emballage plastique.

5-(4-Fluorophenyl)pentan-1-amine, 95%, 1g

(R)?-5,?5',?6,?6',?7,?7',?8,?8'-Octahydro-?3,?3'-?bis(2,?4,?6-?trimethylphenyl)?-[1,?1'-?binaphthalene]?-?2,?2'-?diol, 97%, 100mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 95%, 250mg

3-Bromo-2,6-dichloroaniline, 95.0%, 1g

EMPA, 95%, 25mg

1-(3,5-Difluorophenyl)ethylamine, 97.0%, 10g

4-Bromo-3-(trifluoromethoxy)benzaldehyde, 95.0%, 250mg